contents dedicated
to healthcare professionals
to healthcare
professionals
Gastroenterology
| Title | Date | Author | Download |
|---|---|---|---|
|
Role of Lactobacillus reuteri DSM 17938 on Crying Time Reduction in Infantile Colic and Its Impact on Maternal Depression: A Real-Life Clinic-Based Study |
07/01/2022 |
A. Wadhwa |
|
|
The Biotherapeutic Potential of Lactobacillus reuteri Characterized Using a Target-Specific Selection Process |
15/04/2020 |
M Elli, V. Sagheddu |
|
|
Studio Preliminare Per Valutare Efficacia e Sicurezza di Pentabiocel, un Probiotico Multiceppo, nell’Uso Clinico Del Trattamento della Sindrome dell’Intestino Irritabile |
31/10/2019 |
E. Corazziari |
|
|
Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients With Persistent IBS-type Symptoms |
01/03/2019 |
R. Francavilla |
|
|
Probiotics for management of infantile colic: a systematic review of randomized controlled trials |
05/08/2018 |
H. Szajewska |
|
|
Crying Time and RORγ/FOXP3 Expression in Lactobacillus reuteri DSM17938-Treated Infants with Colic: A Randomized Trial |
01/01/2018 |
F. Savino |
|
|
Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic |
30/11/2017 |
P. Gutierrez-Castrellon |
|
|
Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for diarrhoeal diseases in children |
16/03/2016 |
M. Urbanska |
|
|
Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting |
16/05/2015 |
E. C. Dinleyicia |
|
|
Diarrhea in Preschool Children and Lactobacillus reuteri: A Randomized Controlled Trial |
17/03/2014 |
P. Gutierrez-Castrellon |
|
|
Prophylactic Use of a Probiotic in the Prevention of Colic, Regurgitation, and Functional Constipation |
13/01/2014 |
F. Indrio |
|
|
Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea - a double-blind study |
21/05/2012 |
R. Francavilla |
|
Respiratory
| Title | Date | Author | Download |
|---|---|---|---|
|
Attività anti SARS-CoV2 di una nuova formulazione a base di resveratrolo e carbossimetilbetaglucano |
28/06/2021 |
I. Castagliuolo |
|
|
Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19? |
19/05/2021 |
P. Mastromarino |
|
|
The potential role of Trans-Resveratrol/ Carboxymethylated (1.3/1.6)-β-d-Glucan minimizing symptoms and improve healing after functional endoscopic sinus surgery |
01/12/2020 |
F. Salvinelli |
|
|
Therapeutic Potential of resveratrol against emerging respiratory viral infections |
17/06/2020 |
S. Filardo |
|
|
Resveratrol plus carboxymethyl-β-glucan in infants with common cold: A randomized double-blind trial |
01/04/2020 |
M. E. Baldassarre |
|
|
Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia |
19/08/2015 |
P. Mastromarino |
|
|
Resveratrol plus carboxymethyl-β-glucan in children with recurrent respiratory infections: a preliminary and real-life experience |
23/11/2014 |
A. M. Varricchio |
|
|
Resveratrol plus carboxymethyl-b-glucan may affect respiratory infections in children with allergic rhinitis |
02/11/2014 |
M. Miraglia Del Giudice |
|
|
Resveratrol plus carboxymethyl-b-glucan reduces nasal symptoms in children with pollen-induced allergic rhinitis |
07/07/2014 |
M. Miraglia Del Giudice |
|
Immunity
| Title | Date | Author | Download |
|---|---|---|---|
|
Oral Supplementation With Probiotic Lactobacillus Reuteri DSM 17938 And Vitamind Improves Gastrointestinal Symptoms And Increases Mean Circulating 25- Hydroxyvitamin D In Covid-19 |
20/05/2021 |
A. Mastroianni |
|
|
Lactobacillus reuteri DSM 17938 plus vitamin D3 as ancillary treatment in allergic children with asthma |
01/01/2016 |
M. Miraglia del Giudice |
|
